An Enhanced Anti-Coagulant

1210-img

Tech ID

P27-1210

Patent Status

Granted in India

Design Status

--

Technical Description

The invention introduces a novel anticoagulant formulation, known as Pegylated Dabigatran (PEG-DAB), offers improved pharmacokinetics and pharmacodynamics. It effectively prevents blood clot formation, reducing the risk of stroke and other complications. Notably, PEG-DAB also alleviates neurological deficits.

Problems Addressed

TARGET AUDIENCE

TECH FEATURES

P27-1210

DOWNLOAD

Send download link to email.

Available For

Available for exclusive and non exclusive license
Sell off

Cost

Stage of Developments

Technology Validated

Contact Person

Mr. Lalit Ambastha

IP Bazzaar Technology Pvt. Ltd.

IP Bazzaar Technology Pvt. Ltd.

12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com

Subscribe to Our Latest Updates!

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

Intellectual Property Rights | Technology Monetization | IP Merger & Acquisition- IP Bazzaar will use the information you provide on this form to be in touch with you and to provide updates and marketing.